[go: up one dir, main page]

DK8591A - Interleukin-l inhibitor - Google Patents

Interleukin-l inhibitor Download PDF

Info

Publication number
DK8591A
DK8591A DK008591A DK8591A DK8591A DK 8591 A DK8591 A DK 8591A DK 008591 A DK008591 A DK 008591A DK 8591 A DK8591 A DK 8591A DK 8591 A DK8591 A DK 8591A
Authority
DK
Denmark
Prior art keywords
interleukin
inhibitor
Prior art date
Application number
DK008591A
Other languages
English (en)
Other versions
DK8591D0 (da
DK172763B1 (da
Inventor
Charles H Hannum
Stephen P Eisenberg
Robert C Thompson
William P Arend
Fenneke G Joslin
Andreas Sommer
Original Assignee
Synergen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synergen Inc filed Critical Synergen Inc
Publication of DK8591D0 publication Critical patent/DK8591D0/da
Publication of DK8591A publication Critical patent/DK8591A/da
Application granted granted Critical
Publication of DK172763B1 publication Critical patent/DK172763B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK199100085A 1988-05-27 1991-01-18 Isoleret interleukin-1 (IL-1) inhibitor eller forstadiepolypeptid dertil, isoleret DNA-molekyle, som koder derfor, vektor o DK172763B1 (da)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US19991588A 1988-05-27 1988-05-27
US19991588 1988-05-27
US23871388A 1988-08-31 1988-08-31
US23871388 1988-08-31
US26653188A 1988-11-03 1988-11-03
US26653188 1988-11-03
PCT/US1989/002275 WO1989011540A1 (en) 1988-05-27 1989-05-25 Interleukin-1 inhibitors
US8902275 1989-05-25

Publications (3)

Publication Number Publication Date
DK8591D0 DK8591D0 (da) 1991-01-18
DK8591A true DK8591A (da) 1991-01-18
DK172763B1 DK172763B1 (da) 1999-07-05

Family

ID=27394086

Family Applications (1)

Application Number Title Priority Date Filing Date
DK199100085A DK172763B1 (da) 1988-05-27 1991-01-18 Isoleret interleukin-1 (IL-1) inhibitor eller forstadiepolypeptid dertil, isoleret DNA-molekyle, som koder derfor, vektor o

Country Status (9)

Country Link
JP (2) JP3192651B2 (da)
KR (1) KR970002917B1 (da)
BR (1) BR8907457A (da)
DK (1) DK172763B1 (da)
FI (2) FI109206B (da)
HU (3) HU9803037D0 (da)
NO (2) NO316122B1 (da)
OA (1) OA09631A (da)
WO (1) WO1989011540A1 (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6858409B1 (en) 1988-05-27 2005-02-22 Amgen Inc. Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors
US5075222A (en) 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
US6159460A (en) * 1988-05-27 2000-12-12 Amgen Inc. Method for treating interleukin-1 mediated diseases
US5872095A (en) * 1990-05-01 1999-02-16 Chiron Corporation IL-1 receptor antagonists medicaments
ATE178094T1 (de) * 1990-05-01 1999-04-15 Chiron Corp Interleukin-i antagonist und seine verwendung
US5747444A (en) * 1990-10-09 1998-05-05 Chiron Corporation Method of treating graft-versus-host disease
US5932537A (en) * 1990-10-09 1999-08-03 Chiron Corporation Method for attenuating a cellular response to IL-1
ZA921120B (en) 1991-02-19 1993-01-27 Smithkline Beecham Corp Cytokine inhibitors
US6294170B1 (en) 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
US20030103978A1 (en) 2000-02-23 2003-06-05 Amgen Inc. Selective binding agents of osteoprotegerin binding protein
PH12012502439A1 (en) 2001-06-26 2013-06-17 Amgen Inc Antibodies to opgl
AU2002346882A1 (en) * 2001-10-26 2003-05-06 Novartis Ag Methods for the treatment of osteoarthritis and compositions thereof
JP4761710B2 (ja) 2002-04-05 2011-08-31 アムジェン インコーポレイテッド 選択的opgl経路インヒビターとしてのヒト抗opgl中和抗体
US7709611B2 (en) 2004-08-04 2010-05-04 Amgen Inc. Antibodies to Dkk-1
SI2188313T1 (en) 2007-08-21 2018-04-30 Amgen, Inc. HUMAN C-FMS ANTIGEN TRANSFER PROTEIN
WO2010030979A2 (en) * 2008-09-12 2010-03-18 Xbiotech, Inc. Targeting pathogenic monocytes
WO2012025910A1 (en) 2010-08-26 2012-03-01 Centro De Investigación Y De Estudios Avanzados Del Instituto Politécnico Nacional METHODS OF DIAGNOSIS AND TREATMENT OF OSTEOARTHRITIS AT EARLY STAGES USING INTERLEUKIN IL-1ß AS EARLY BIOMARKER OF THE DISEASE
WO2012122985A1 (en) 2011-03-14 2012-09-20 University Of Copenhagen Antagonists of the interleukin- 1 receptor
US20140308294A1 (en) 2011-04-15 2014-10-16 Merck Patent Gmbh Anti-IL-1R1 Inhibitors For Use in Cancer
TW201605896A (zh) 2013-08-30 2016-02-16 安美基股份有限公司 Gitr抗原結合蛋白
WO2015087187A1 (en) 2013-12-10 2015-06-18 Rinat Neuroscience Corp. Anti-sclerostin antibodies
TWI742054B (zh) 2016-03-08 2021-10-11 美商健生生物科技公司 Gitr抗體,方法及用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8820676A (nl) * 1987-08-26 1989-07-03 Biogen Inc Biologische materialen, werkwijzen ter bereiding van biologische materialen en de toepassing van dergelijke materialen in therapie.

Also Published As

Publication number Publication date
WO1989011540A1 (en) 1989-11-30
FI109206B (fi) 2002-06-14
FI20020545L (fi) 2002-03-21
BR8907457A (pt) 1991-04-02
AU3746989A (en) 1989-12-12
JPH03505279A (ja) 1991-11-21
NO905090D0 (no) 1990-11-23
FI20020545A7 (fi) 2002-03-21
HU9803037D0 (en) 1999-11-29
HU893412D0 (en) 1991-05-28
NO20014783L (no) 1991-01-28
NO316122B1 (no) 2003-12-15
NO905090L (no) 1991-01-28
HU222810B1 (hu) 2003-11-28
NO316917B1 (no) 2004-06-21
KR970002917B1 (ko) 1997-03-12
NO20014783D0 (no) 2001-10-01
DK8591D0 (da) 1991-01-18
HU215434B (hu) 1999-04-28
OA09631A (en) 1993-04-30
DK172763B1 (da) 1999-07-05
JP2001029093A (ja) 2001-02-06
AU633831B2 (en) 1993-02-11
JP3192651B2 (ja) 2001-07-30
FI905812A0 (fi) 1990-11-26

Similar Documents

Publication Publication Date Title
FR2632154B1 (fr) Moissonneuse
ATA901789A (de) Somatostatinpeptid
BR8806093A (pt) Trepano
DK8591A (da) Interleukin-l inhibitor
ATA172889A (de) Furanderivate
ATA900689A (de) Calcitoninpeptide
DK348289D0 (da) Forbindelser
DK381889D0 (da) Benzamidderivater
DK476689D0 (da) Polyisocyanatmateriale
DE68926597D1 (de) Mikrorechner
BR8902098A (pt) Eletrolisador
DK113291A (da) Homogent enzymimmunassay
BR8906898A (pt) Jamela
DK69489A (da) Aspartattranscarbamylase-inhibitorer
DE68926367D1 (de) Hydroxymethylcyclobutylpurine
KR890023207U (ko) 관계수
DD277186A3 (de) Waelzlagerseparator
SE8901229D0 (sv) Minor
KR890018967U (ko) 렌치
BR8803070A (pt) Rende-lapis
BR6802833U (pt) Municao subcalibrada - 90mm
BR6802550U (pt) Bicicleta-skate
BR8801701A (pt) Anti-ivh
BR6801330U (pt) Caixa-arquivo
BR6801307U (pt) Boneco-luva

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment
AGE Re-establishment of rights: approved
B1 Patent granted (law 1993)
PUP Patent expired